Role of Interleukin-6 in Depressive Disorder

Abstract

Major depressive disorder (MDD), which is a leading psychiatric illness across the world, severely affects quality of life and causes an increased incidence of suicide. Evidence from animal as well as clinical studies have indicated that increased peripheral or central cytokine interleukin-6 (IL-6) levels play an important role in stress reaction and depressive disorder, especially physical disorders comorbid with depression. Increased release of IL-6 in MDD has been found to be a factor associated with MDD prognosis and therapeutic response, and may affect a wide range of depressive symptomatology. However, study results of the IL6 genetic effects in MDD are controversial. Increased IL-6 activity may cause depression through activation of hypothalamic-pituitary-adrenal axis or influence of the neurotransmitter metabolism. The important role of neuroinflammation in MDD pathogenesis has created a new perspective that the combining of blood IL-6 and other depression-related cytokine levels may help to classify MDD biological subtypes, which may allow physicians to identify the optimal treatment for MDD patients. To modulate the IL-6 activity by IL-6-related agents, current antidepressive agents, herb medication, pre-/probiotics or non-pharmacological interventions may hold great promise for the MDD patients with inflammatory features.

Long-Term Exposure to Ceftriaxone Sodium Induces Alteration of Gut Microbiota Accompanied by Abnormal Behaviors in Mice

“…In a study, IL-6 knockout mice became resistant to the development of depression-like symptoms (Monje et al, 2011 ). The underlying mechanisms involve in two pathways, the HPA axis and neurotransmitter metabolism, both of which are affected by increased IL-6 in depression (Ting et al, 2020 ). Furthermore, anxious patients also had higher serum levels of IL-6 than common people (Tang et al, 2018 ; Zou et al, 2020 ).…”

Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines -two case reports

“…It was apparent that there is an inverse correlation between the serum IL-6 level and prefrontal cortex thickness. Sleep disturbance and impairment in sustained attention was positively related to an increase in IL-6 level ( 34 ). Patients with cancers such as lung, ovarian, colorectal, pancreatic, and others show higher levels of IL-6 compared to healthy controls.…”

“…It was found that improvement in depressive symptoms in these patients was correlated with normalization of IL-6 levels. Symptoms such as anorexia, insomnia, and fatigue were significantly associated with elevated IL-6 levels ( 34 ).…”

LTBP1 plays a potential bridge between depressive disorder and glioblastoma

“…As two of the most common types of psychological disorders, depression and anxiety had caused millions of morbidity and mortality each year all over the world [6]. It was confirmed that many biological [7,8], genetical [9], psychological [10], and social environmental [11] factors are involved in the pathogenesis of depression and anxiety. Psychological disorders can often affect one's physical health in a variety of known or unknown ways.…”